What drugs does PLD ACQUISITIONS LLC make?

PLD ACQUISITIONS LLC has 9 FDA-approved drugs.

What therapeutic areas does PLD ACQUISITIONS LLC focus on?

PLD ACQUISITIONS LLC focuses primarily on Neurology and Immunology.

← Back

Data updated: Mar 10, 2026

PLD ACQUISITIONS LLC

NeurologyImmunology

Generics

PLD ACQUISITIONS LLC is a generic drug manufacturer focused on Neurology, Immunology.

1993

Since

Drugs

Trials

Approved (2yr)

Key Drugs

No active drugs

Recent Activity

NICOTINE POLACRILEX 2026-02-05

Labeling

CETIRIZINE HYDROCHLORIDE ALLERGY 2026-01-30

Labeling

NAPROXEN SODIUM 2026-01-24

Labeling

NAPROXEN SODIUM 2026-01-24

Labeling

NAPROXEN SODIUM 2026-01-24

Labeling

NAPROXEN SODIUM 2026-01-15

Labeling

NAPROXEN SODIUM 2025-09-16

Labeling

NAPROXEN SODIUM 2025-09-16

Labeling

NAPROXEN SODIUM 2025-09-16

Labeling

NAPROXEN SODIUM 2025-09-16

Labeling

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 50%

1 drugs

Immunology 50%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

AbbVie big-pharma

Immunology, Neurology

GSK big-pharma

Immunology, Neurology

Eli Lilly big-pharma

Immunology, Neurology

Roche big-pharma

Neurology, Immunology

Bristol-Myers Squibb big-pharma

Immunology, Neurology

PLD ACQUISITIONS LLC

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (9)

Active (6)

Discontinued (2)

Company Info